Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,938.08
+64.04
(+0.54%)
NZD/USD
0.6014
+0.0051
(+0.85%)
NZD/EUR
0.5580
+0.0024
(+0.44%)
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
OIL
78.07
-0.88
(-1.11%)
Galectin Therapeutics Inc. (GALT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3400
-0.0300
(-0.89%)
At close: 04:00PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
32,130
32,130
31,737
23,818
17,976
Selling general and administrative
5,942
5,942
6,615
6,361
5,468
Total operating expenses
38,072
38,072
38,352
30,179
23,444
Operating income or loss
-38,072
-38,072
-38,352
-30,179
-23,444
Interest expense
2,792
2,792
1,033
489
87
Total other income/expenses net
-432
-432
557
138
-
Income before tax
-41,066
-41,066
-38,776
-30,527
-23,465
Income from continuing operations
-41,066
-41,066
-38,776
-30,527
-23,465
Net income
-41,066
-41,066
-38,776
-30,527
-23,465
Net income available to common shareholders
-44,805
-44,805
-38,873
-30,698
-23,602
Basic EPS
-0.39
-0.74
-0.65
-0.52
-0.41
Diluted EPS
-0.39
-0.74
-0.65
-0.52
-0.41
Basic average shares
52,238
60,159
59,391
58,527
57,029
Diluted average shares
52,238
60,159
59,391
58,527
57,029
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.